DrugCard stands as a cutting-edge AI-powered tool meticulously crafted to excel in local literature screening, serving as an indispensable asset to the pharmaceutical industry. Its primary mission is to optimize drug safety protocols while ensuring unwavering compliance with the stringent regulatory standards that govern the field.
This adept tool operates on the principle of continuous and routine screening, empowering pharmaceutical enterprises to remain impeccably informed about the latest developments within their local markets. Its distinctive hallmark lies in endowing users with an invaluable sense of traceability and transparency, thereby enabling them to meticulously monitor the screening process’s accuracy, comprehensiveness, and integrity.
One of the defining features of DrugCard is its remarkable scalability, which seamlessly accommodates pharmaceutical companies poised for global expansion. With its versatility extending across multiple languages and suppliers, it facilitates a thorough and exhaustive screening regimen.
What sets DrugCard apart as a standout solution is its cost-effectiveness, as it obviates the need for burdensome capital investments, presenting a prudent choice for pharmaceutical entities. Operating across more than 100 languages and diligently covering medical journals hailing from over 35 countries, DrugCard leaves no stone unturned in its comprehensive screening efforts, boasting an impressive accuracy rate in scanned PDF screening.
In essence, DrugCard caters to an array of users within the pharmaceutical landscape, including Contract Research Organizations (CROs), Marketing Authorization Holders (MAHs), and freelancers. It empowers CROs to efficiently manage a multitude of projects while elevating the quality of screening outcomes. MAHs can opt for in-house screening to effectively mitigate compliance and reputation-related risks. Freelancers, too, reap the rewards by reclaiming valuable time from literature screening, enabling a focus on other value-added endeavors.
In summation, DrugCard stands as a steadfast and efficient ally in the realm of local literature screening. It equips the pharmaceutical sector with indispensable tools, ensuring the streamlining of drug safety procedures and unwavering adherence to the rigorous regulatory prerequisites that define the industry.